Current Edition

Tunisia – A Focus on the Clinical Trials Landscape

Tunisia – A Focus on the Clinical Trials Landscape
Shifting clinical trials to North Africa is an up-to-date consideration for pharma development leaders for a multitude of reasons. Major concerns facing these decision- makers are development timelines, avaibility of drug-naive patients, compliance with good clinical practice, logistics and handling of IMPs, and quality of data provided. In this issue, Chiheb Guerfel of Poseidon Pharma explains the conditions of conducting clinical trials in Tunisia.
http://jforcs.com/jcs/wp-content/uploads/2013/04/Tunisia-A-Focus-on-the-Clinical-Trials-Landscape.pdf